Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
- 1 January 2005
- journal article
- Published by Taylor & Francis in Climacteric
- Vol. 8 (4) , 307-310
- https://doi.org/10.1080/13697130500345505
Abstract
The Women's Health Initiative (WHI) trials have provided us with valuable information on the effect of hormone therapy (HT) in older postmenopausal women. These results have been generalized to women of all ages, despite the fact that the trials were not powered to evaluate the effect of HT in younger women who initiate treatment shortly after menopause. Pooled data from the WHI and other randomized trials now reveal that HT in younger women is associated with a reduction in coronary heart disease events and total mortality, a benefit that is not seen in older women.Keywords
This publication has 21 references indexed in Scilit:
- Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapiesClimacteric, 2005
- The Women's Health Initiative Reports in perspective: facts or fallacies?Climacteric, 2004
- Hormone therapy use after the Women's Health InitiativeClimacteric, 2004
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapyObstetrics & Gynecology, 2003
- Estrogen plus Progestin and the Risk of Coronary Heart DiseaseNew England Journal of Medicine, 2003
- Postmenopausal Hormones — Therapy for Symptoms OnlyNew England Journal of Medicine, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONSAnnual Review of Public Health, 1998
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996